Xinjiang Tianshan Animal Husbandry Bio-engineering (300313) Stock Overview
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
300313 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.Read more
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.11 |
| 52 Week High | CN¥11.80 |
| 52 Week Low | CN¥4.66 |
| Beta | 0.013 |
| 1 Month Change | 10.49% |
| 3 Month Change | -14.90% |
| 1 Year Change | 57.78% |
| 3 Year Change | 49.63% |
| 5 Year Change | -41.23% |
| Change since IPO | 5.32% |
Recent News & Updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE:300313)
Jan 01
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE:300313) Investors Are Less Pessimistic Than Expected
Oct 02Some Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE:300313) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 27Some Confidence Is Lacking In Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE:300313) As Shares Slide 35%
Apr 19What Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.'s (SZSE:300313) 44% Share Price Gain Is Not Telling You
Mar 05Shareholder Returns
| 300313 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 0.2% | 0.7% | 2.7% |
| 1Y | 57.8% | 4.7% | 35.3% |
Return vs Industry: 300313 exceeded the CN Biotechs industry which returned 5.5% over the past year.
Return vs Market: 300313 exceeded the CN Market which returned 34.9% over the past year.
Price Volatility
| 300313 volatility | |
|---|---|
| 300313 Average Weekly Movement | 7.4% |
| Biotechs Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in CN Market | 9.9% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 300313 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300313's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 124 | Jianjun Ge | www.xjtssw.com |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the provision of cattle breeding products and services in China. The company offers frozen semen and embryos of self-produced bulls and products, including breeds of Holstein, Brown, Simmental, Charolais, Angus, and Limousin; fattening cattle; and sheep frozen semen and embryo products.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. Fundamentals Summary
| 300313 fundamental statistics | |
|---|---|
| Market cap | CN¥1.94b |
| Earnings (TTM) | -CN¥36.02m |
| Revenue (TTM) | CN¥89.79m |
Is 300313 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300313 income statement (TTM) | |
|---|---|
| Revenue | CN¥89.79m |
| Cost of Revenue | CN¥93.80m |
| Gross Profit | -CN¥4.01m |
| Other Expenses | CN¥32.01m |
| Earnings | -CN¥36.02m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 25, 2026
| Earnings per share (EPS) | -0.15 |
| Gross Margin | -4.47% |
| Net Profit Margin | -40.11% |
| Debt/Equity Ratio | 214.6% |
How did 300313 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/17 07:06 |
| End of Day Share Price | 2026/04/17 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jinhou Zhao | SWS Research Co., Ltd. |